Decorative dot pattern background image.
Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image.

S1914

Trial Overview

Official Title

A randomized Phase III Trial of Induction/consolidation Atezolizumab (NSC #783608) + SBRT Alone in High Risk, Early Stage NSCL

Study Purpose

To compare overall survival in patients with inoperable, early stage non-small cell lung cancer (NSCLC) randomized to stereotactic body radiation therapy (SBRT) with or without atezolizumab

Diagnosis

Minimally invasive adenocarcinoma NSCLC

Eligibility

Stage I-IIA or Limited Stage III disease undergone a diagnostic CT and PET scan and biopsy, no nodal involvement, must be medically or surgically inoperable

 

Intervention

Treatment ARM A

Atezolizumab for 8 cycles and Stereotactic body radiation

 

Treament ARM B

Stereotactic radiation

For more information, click the link below:

 

https://clinicaltrials.gov/study/NCT04214262?term=S1914&rank=1

 

Key Participation Requirements
Trial Location(s)
Methodist Estabrook Cancer Center Methodist Jennie Edmundson Hospital
Gender
Male or Female
Age
19 years and older
Enrollment Status
Suspended
Phase
Phase III